Cardiology

ACC: Faster absorption of crushed prasugrel in STEMI

(HealthDay)—Crushed prasugrel correlates with faster drug absorption for patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI), according to a study ...

Oncology & Cancer

SCCM: circulating histones for most with thrombocytopenia

(HealthDay)—Most patients with thrombocytopenia have circulating histones, according to a research letter published online Feb. 22 in the Journal of the American Medical Association to coincide with the Society of Critical ...

Medical research

New treatment option for the acute phase of the rare disease TTP

Thrombotic Thrombocytopenic Purpura (TTP) is a rare disorder caused by an enzyme deficiency. This can be heriditary or can be acquired as an autoimmune condition. Due to the associated excessive activity of a certain protein, ...

Medical research

Biophysicists develop a model for arterial thrombus formation

A group of biophysicists, including representatives from Moscow Institute of Physics and Technology, have developed a mathematical model of arterial thrombus formation, which is the main cause of heart attacks and strokes. ...

Oncology & Cancer

Blood sample new way of detecting cancer

A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood. Using this new method for blood-based RNA tests of blood platelets, ...

Oncology & Cancer

Lonsurf approved for advanced colon cancer

(HealthDay)—The combination pill Lonsurf (trifluridine and tipiracil) has been approved by the U.S. Food and Drug Administration to treat advanced colon cancer for people who aren't responding to other treatments, the agency ...

page 20 from 32